ORG Partners LLC Reduces Holdings in Oracle Corporation $ORCL

Key Points

• ORG Partners LLC has reduced its stake in Oracle Corporation by 65.6%, now holding just 2,466 shares worth approximately $540,000.
• In recent analyst reports, Oracle's price targets have been significantly raised, with notable upgrades from firms like Piper Sandler and Cowen, pushing Oracle's target price as high as $375.00.
• Insider selling activity has been notable, with Director William G. Parrett and others selling a combined 112,092 shares worth over $32.9 million in the last quarter.

ORG Partners LLC lessened its stake in Oracle Corporation (NYSE:ORCL - Free Report) by 65.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,466 shares of the enterprise software provider's stock after selling 4,700 shares during the quarter. ORG Partners LLC's holdings in Oracle were worth $540,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Legend Financial Advisors Inc. bought a new position in shares of Oracle during the 2nd quarter worth about $34,000. Redmont Wealth Advisors LLC acquired a new position in shares of Oracle in the first quarter valued at $27,000. Inlight Wealth Management LLC bought a new stake in Oracle during the first quarter worth about $28,000. Iron Horse Wealth Management LLC raised its holdings in Oracle by 284.9% in the 1st quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock valued at $29,000 after buying an additional 151 shares during the last quarter. Finally, Family Legacy Financial Solutions LLC acquired a new stake in shares of Oracle during the 2nd quarter worth approximately $60,000. Hedge funds and other institutional investors own 42.44% of the company's stock.

Analyst Upgrades and Downgrades

ORCL has been the subject of several recent analyst reports. UBS Group set a $364.00 price objective on Oracle in a report on Friday. Piper Sandler lifted their target price on Oracle from $270.00 to $330.00 and gave the company an "overweight" rating in a research note on Wednesday, September 10th. Cowen reaffirmed a "buy" rating and issued a $375.00 price objective on shares of Oracle in a research note on Wednesday, September 10th. Melius Research lifted their target price on Oracle from $270.00 to $370.00 and gave the stock a "buy" rating in a report on Wednesday, September 10th. Finally, The Goldman Sachs Group lifted their target price on Oracle from $195.00 to $310.00 and gave the stock a "neutral" rating in a report on Monday, September 15th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat.com, Oracle presently has a consensus rating of "Moderate Buy" and a consensus price target of $304.71.

Insider Buying and Selling at Oracle

In other Oracle news, Director William G. Parrett sold 11,500 shares of Oracle stock in a transaction on Friday, September 12th. The shares were sold at an average price of $306.00, for a total transaction of $3,519,000.00. Following the transaction, the director directly owned 17,764 shares of the company's stock, valued at $5,435,784. The trade was a 39.30% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Clayton M. Magouyrk sold 21,241 shares of the company's stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the sale, the insider directly owned 78,000 shares in the company, valued at approximately $23,174,580. This trade represents a 21.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 112,092 shares of company stock worth $32,960,165 over the last quarter. Insiders own 42.20% of the company's stock.

Oracle Stock Performance

NYSE:ORCL opened at $283.29 on Friday. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. The firm's 50-day moving average is $258.19 and its 200-day moving average is $200.78. Oracle Corporation has a 52-week low of $118.86 and a 52-week high of $345.72. The company has a market cap of $805.03 billion, a price-to-earnings ratio of 65.58, a PEG ratio of 3.05 and a beta of 1.46.

Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same period last year, the firm earned $1.39 earnings per share. The company's quarterly revenue was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities research analysts anticipate that Oracle Corporation will post 5 earnings per share for the current year.

Oracle Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Thursday, October 9th. Oracle's dividend payout ratio (DPR) is presently 46.30%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.